Is "Pangolin (Manis Squama) is not used in medicine" an improvement in the protection of precious and rare species or an improvement in the safety of using medicine?

• 作者: Bao-Tong Li Xiang-Long Meng Xiao-Juan Su Yi Zhou
• 来源期刊: 传统医学研究（英文版）
• 年，卷（期）: 2020,（6）
• 所属期刊栏目: News
• 页码范围: 425-427
• 页数: 3页
• 语种: 英文
• DOI: 10.12032/TMR20201001201

摘要

Recently, a number of reports about pangolin have become hot news:The Chinese Pharmacopoeia (2020 edition) has not continued to include the drug-using standards for pangolin (Manis Squama), aristolochic (Aristolochia debilis Sieb. et Zucc), celestial vine (Fibraurea recisa Pierre), and Chinese patent drug Huanglian Yanggan pills (approval number by China State Food and Drug Administration: Z200113194).